TP Therapeutics' Series C Round

TP Therapeutics raised a round of funding on May 23, 2017.

TP Therapeutics, Inc. (TP) is a structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. The company focuses on the design of novel c…

Articles about TP Therapeutics' Series C Round: